The White Rose Consortium Institutes are developing a contractual statement defining the purposes for which they transmit personal data and the standards they exploit. The conditions are made available to applicants and students as soon as possible. If you prefer that we don`t do the above activity, Please email [email protected] or call 0113 34 36541 context and study objectivesThe objective of this study is to: assess the effectiveness of family therapy (FT) compared to treatment as Usual (TAU) for adolescents aged 11 to 17 years who have committed at least one episode of previous self-injury, in terms of the recidivism rate of self-injury leading to a hospital visit over an 18-month period. Who can participate? The study aimed to recruit 832 families (young people aged 11 to 17 who participated in at least one previous episode of self-injury and their parents/caregivers) over three years by Child and Adolescent Mental Health Services (CAMHS) in Yorkshire, Greater Manchester and London. Families who agreed to participate in the study were randomly assigned to either TAU (standard care by the local CAHMS team) or FT (by specific family therapists). When awarded to FT, families were invited to attend some eight ft meetings over a six-month period, depending on individual needs. All families were then followed after 3, 6, 12 and 18 months to complete questionnaires and assessments. What are the potential benefits and risks of participating? The trial team does not expect any other risks when participating in this study. Although the team hopes that families who complete family therapy will find the treatment useful, we cannot say that this treatment will definitely help. The same is true for families who are not involved in the process.
The main advantage is that the research project will help us learn more about how we can help people who have self-damaged in the future. Where did the study come from? The study is being led by a team of researchers from the University of Leeds, in collaboration with researchers from the University of Manchester and King`s College London. When will the study begin and how long should it last? The first family was recruited for the trial in April 2010. The study was discontinued in December 2013 (44 months) after the complete sample required for statistical analysis was discontinued. The study is now in the next phase, before the final analysis, with the expected results by early 2016. Who is funding the study? NIHR Health Technology Assessment Programme – HTA (UK)Who is the main contact? Chief Investigator – Professor David Cottrell, University of Leeds ([email protected]) Senior Trial Manager – Frau Liz Graham, University of Leeds ([email protected]) We will collect and process personal data about you.